4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001410289-25-000006
CEO and President acquired 550,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Szela Mary T CEO and President | 2024-02-13 | Grant or award | +125,000 | 317,802 | D: show line 1 in the form | ||
| Szela Mary T CEO and President | 2025-11-24 | Grant or award | +125,000 | 442,802 | D: show line 2 in the form | ||
| Szela Mary T CEO and President | 2025-11-24 | Grant or award | +300,000 | 742,802 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Szela Mary T CEO and President | 2025-11-24 | Grant or award · Employee Stock Option (right to buy) | +250,000 | 1,578,182 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1764104104.xml…